Unknown

Dataset Information

0

In-silico Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV-2.


ABSTRACT: Due to alarming outbreak of pandemic COVID-19 in recent times, there is a strong need to discover and identify new antiviral agents acting against SARS CoV-2. Among natural products, lignan derivatives have been found effective against several viral strains including SARS CoV-2. Total of twenty-seven reported antiviral lignan derivatives of plant origin have been selected for computational studies to identify the potent inhibitors of SARS CoV-2. Molecular docking study has been carried out in order to predict and describe molecular interaction between active site of enzyme and lignan derivatives. Out of identified hits, clemastatin B and erythro-strebluslignanol G demonstrated stronger binding and high affinity with all selected proteins. Molecular dynamics simulation studies of clemastin B and savinin against promising targets of SARS CoV-2 have revealed their inhibitory potential against SARS CoV-2. In fine, in-silico computational studies have provided initial breakthrough in design and discovery of potential SARS CoV-2 inhibitors.

SUBMITTER: Sureja DK 

PROVIDER: S-EPMC9349937 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>In-silico</i> Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV-2.

Sureja Dipen K DK   Shah Ashish P AP   Gajjar Normi D ND   Jadeja Shwetaba B SB   Bodiwala Kunjan B KB   Dhameliya Tejas M TM  

ChemistrySelect 20220726 28


Due to alarming outbreak of pandemic COVID-19 in recent times, there is a strong need to discover and identify new antiviral agents acting against SARS CoV-2. Among natural products, lignan derivatives have been found effective against several viral strains including SARS CoV-2. Total of twenty-seven reported antiviral lignan derivatives of plant origin have been selected for computational studies to identify the potent inhibitors of SARS CoV-2. Molecular docking study has been carried out in or  ...[more]

Similar Datasets

| S-EPMC7212546 | biostudies-literature
| S-EPMC7893092 | biostudies-literature
| S-EPMC7640924 | biostudies-literature
| S-EPMC9979702 | biostudies-literature
| S-EPMC8372460 | biostudies-literature
| S-EPMC9494209 | biostudies-literature
| S-EPMC9803264 | biostudies-literature
| S-EPMC7765764 | biostudies-literature
| S-EPMC7826501 | biostudies-literature
| S-EPMC9581031 | biostudies-literature